MDxHealth Average Inventory from 2010 to 2026
| MDXH Stock | USD 3.65 0.05 1.35% |
Average Inventory | First Reported 2010-12-31 | Previous Quarter 132.3 K | Current Value 83.4 K | Quarterly Volatility 35 K |
Check MDxHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MDxHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.7 M, Interest Expense of 9.2 M or Selling General Administrative of 66.4 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 7.34. MDxHealth financial statements analysis is a perfect complement when working with MDxHealth Valuation or Volatility modules.
MDxHealth | Average Inventory | Build AI portfolio with MDxHealth Stock |
Latest MDxHealth's Average Inventory Growth Pattern
Below is the plot of the Average Inventory of MDxHealth SA ADR over the last few years. It is the average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. MDxHealth's Average Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MDxHealth's overall financial position and show how it may be relating to other accounts over time.
| Average Inventory | 10 Years Trend |
|
Average Inventory |
| Timeline |
MDxHealth Average Inventory Regression Statistics
| Arithmetic Mean | 127,302 | |
| Geometric Mean | 121,157 | |
| Coefficient Of Variation | 27.49 | |
| Mean Deviation | 28,391 | |
| Median | 146,996 | |
| Standard Deviation | 34,998 | |
| Sample Variance | 1.2B | |
| Range | 85.5K | |
| R-Value | 0.42 | |
| Mean Square Error | 1.1B | |
| R-Squared | 0.18 | |
| Significance | 0.09 | |
| Slope | 2,902 | |
| Total Sum of Squares | 19.6B |
MDxHealth Average Inventory History
About MDxHealth Financial Statements
Investors use fundamental indicators, such as MDxHealth's Average Inventory, to determine how well the company is positioned to perform in the future. Although MDxHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Average Inventory | 132.3 K | 83.4 K |
Currently Active Assets on Macroaxis
When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:Check out the analysis of MDxHealth Correlation against competitors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is there potential for Biotechnology market expansion? Will MDxHealth introduce new products? Factors like these will boost the valuation of MDxHealth. Expected growth trajectory for MDxHealth significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share | Quarterly Revenue Growth 0.177 | Return On Assets | Return On Equity |
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that MDxHealth's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MDxHealth represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, MDxHealth's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.